United States · 
Who invested in BioSurplus?
BioSurplus's investors include KI Investment Holdings and SJF Ventures.
2013
$1.5MVenture$2.4MSeries A
United States · Series A startup
Who invested in BioSurplus
Funding summaryUpdated 26 Oct 2026
$3.9Mraised across 2 rounds since 2012, from 2 sources
$1.5MVenture$2.4MSeries A
- Latest round
- Series A, $2.4MJul 2012
- Step-upi
- 1.6×
- Investors
- 2
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Venture, $1.5M May 2012
- Biggest round
- $2.4M Series A · Jul 2012
- Between rounds
- 2 months from the last two
The rounds
- Jul 2012Series A$2.4M1 new1 returning
Reported by finsmes.comSEC filing: $2.4M sold, first sale Mar 2012
- May 2012Venture$1.5M1 new
Reported by masshightech.comSEC filing: $500K sold, first sale Mar 2012
Founders and team
From the SEC filings it signed: 2 on the team.
- Kathleen D ScottExecutive Officer, Directori
- Preston B Plumb VExecutive Officer, Directori
On the board, as filediDavid B GreistJay B Rembolt
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
KI Investment HoldingsVC firm2rounds
Missing a round, or an investor who was in one? Tell us.
Quick answers about BioSurplus
How much has BioSurplus raised?
BioSurplus has raised $3.9M across 2 rounds since 2012.
When did BioSurplus last raise?
BioSurplus's most recent round was a Series A of $2.4M in Jul 2012.
What was BioSurplus's biggest round?
Its most recent round, $2.4M in Jul 2012, is also its largest on record.
Who backed BioSurplus first?
BioSurplus's first round on record, in May 2012, was backed by KI Investment Holdings.
What stage is BioSurplus at?
BioSurplus's latest named round is a Series A, in Jul 2012.
Where is BioSurplus based?
BioSurplus is based in the United States.
Companies like BioSurplus
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.